Bax, Bcl-2, Fas and Fas-L antigen expression in human seminoma:: Correlation with the apoptotic index

被引:23
作者
Grobholz, R
Zentgraf, H
Köhrmann, KU
Bleyl, U
机构
[1] Univ Heidelberg, Univ Hosp Mannheim, Dept Pathol, D-6800 Mannheim, Germany
[2] German Canc Res Ctr, Dept Appl Tumor Virol, D-6900 Heidelberg, Germany
[3] Univ Heidelberg, Univ Hosp Mannheim, Dept Urol, D-6800 Mannheim, Germany
关键词
seminoma; apoptosis; Bax; Bcl-2; Fas; Fas-L;
D O I
10.1034/j.1600-0463.2002.1101006.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Apoptosis plays a crucial role in the regulation of spermatogenesis in male germ cells and is, at least in part, modulated by Bcl-2, Bax, and the Fas pathway. Seminomas have a favourable outcome and respond to radio-/chemotherapy with an increased rate of apoptosis. The expression of Bax, Bcl-2, Fas and Fas-ligand (Fas-L) in human seminoma was evaluated and correlated with the apoptotic index. Twenty-nine classical seminomas were examined by immunohistochemistry and Western blotting using antibodies against Bax, Bcl-2, Fas and Fas-L. Apoptosis was detected by in-situ end-labeling of fragmented DNA and the apoptotic index (AI) was determined. Expression of Fas was found in 26 (89.7%) of Fas-L in 24 seminomas (82.2%); none of the tumours expressed Bcl-2. No correlation between the AI and Fas, Fas-L or Bcl-2 expression was found. Bax was demonstrated in 20/29 tumours (69%). Bax-positive tumours showed an increased AI of 4.75+/-2.38% in contrast to 2.60+/-1.23% of the Bax-negative tumours (P=0.002). The number of Bax-positive tumour cells and apoptotic cells revealed a significant correlation using chi(2)-test (P=0.04) and linear regression (r=0.54, P=0.001). Therefore, Bax seems to play a determinant role in the modulation of apoptosis in human seminoma that may be linked to a favourable outcome.
引用
收藏
页码:724 / 732
页数:9
相关论文
共 50 条
  • [31] 大鼠创伤性脑损伤后Bcl-2及Fas-L的表达
    史为栋
    宋旭东
    秦启生
    王孔宝
    中国法医学杂志, 2003, (02) : 70 - 73
  • [32] Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma
    Magistrelli, P
    Coppola, R
    Tonini, G
    Vincenzi, B
    Santini, D
    Borzomati, D
    Vecchio, F
    Valeri, S
    Castri, F
    Antinori, A
    Nuzzo, G
    Caraglia, M
    Picciocchi, A
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 97 (01) : 98 - 108
  • [33] Apoptosis in cultured rat islets of Langerhans and occurrence of Bcl-2, Bak, Bax, Fas and Fas ligand
    Hanke, J
    CELLS TISSUES ORGANS, 2001, 169 (02) : 113 - 124
  • [34] Bcl-2 and Bax protein expression in human myopathies
    Olivé, M
    Ferrer, I
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 164 (01) : 76 - 81
  • [35] Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors
    Maurillo, L
    Del Poeta, G
    Venditti, A
    Buccisano, F
    Battaglia, A
    Santinelli, S
    Caravita, T
    Epiceno, AM
    Del Moro, B
    Tamburini, A
    Picardi, A
    Suppo, G
    Catalano, G
    Bruno, A
    Amadori, S
    HAEMATOLOGICA, 2001, 86 (03) : 237 - 243
  • [36] Analysis of the Expression of Fas,FasL and Bcl-2 in the Pathogenesis of Autoimmune Thyroid Disorders
    S.M.FazleAkbar
    Cellular & Molecular Immunology, 2004, (03) : 224 - 228
  • [37] Correlation of Bcl-2 and Bax with apoptosis in human pituitary adenomas
    Demetrios Sambaziotis
    Nikiforos Kapranos
    George Kontogeorgos
    Pituitary, 2003, 6 (3) : 127 - 133
  • [38] Analysis of the Expression of Fas, FasL and Bcl-2 in the Pathogenesis of Autoimmune Thyroid Disorders
    Chen, Shenren
    Akbar, S. M. Fazle
    Zhen, Zhichao
    Luo, Yiping
    Deng, Lijuan
    Huang, Haihua
    Chen, Linxin
    Li, Wei
    CELLULAR & MOLECULAR IMMUNOLOGY, 2004, 1 (03) : 224 - 228
  • [40] Expression of Bcl-2 inhibited Fas-mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells
    Yun Chao CHANG
    Yong Hua XU
    Cell Research, 2000, 10 : 233 - 242